BILIARY CARCINOMA

Clinical trials for BILIARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BILIARY CARCINOMA trials appear

Sign up with your email to follow new studies for BILIARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill targets rare bile duct cancer mutation in late-stage trial

Disease control Ongoing

This study tests an experimental pill, TQB3454, against a placebo in 165 people with advanced bile duct cancer that has a specific IDH1 gene mutation. The goal is to see if the drug helps people live longer. Participants are randomly assigned to get the drug or a placebo, and nei…

Matched conditions: BILIARY CARCINOMA

Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Jun 12, 2026 12:07 UTC

BILIARY CARCINOMA

Get alerted when new BILIARY CARCINOMA trials appear

New pill targets rare bile duct cancer mutation in late-stage trial